Which structural feature distinguishes a monobactam from the other beta-lactam classes?

A single, monocyclic beta-lactam ring that is not fused to a second ring — Penicillins, cephalosporins and carbapenems all present their beta-lactam ring attached to a second ring; the monobactam scaffold carries just the one. Aztreonam, the agent that represents this class in practice, was originally obtained from Chromobacterium violaceum.

A beta-lactam ring fused to a thiazolidine ring

Two beta-lactam rings joined in series

How does aztreonam exert its antibacterial effect?

It binds penicillin-binding proteins, so cell-wall synthesis is inhibited and bacterial growth falls — Despite its unusual single-ring scaffold, aztreonam works in the conventional beta-lactam way. It attaches to the transpeptidases that cross-link peptidoglycan, and once wall construction is blocked the organism's growth declines.

It binds the 30S ribosomal subunit and causes misreading of the genetic code

It binds the D-alanyl-D-alanine terminus of the peptidoglycan precursor

It inhibits DNA gyrase and prevents supercoiling

Aztreonam is selected to cover the gram-negative component of an intra-abdominal infection. Which organisms does it leave uncovered?

Gram-positive organisms and anaerobes — This drug's reach stops at aerobic gram-negative bacilli, which is a much narrower profile than a carbapenem offers. Anything gram-positive and anything anaerobic requires a second agent, so relying on aztreonam alone in a mixed abdominal picture leaves a gap.

Enterobacterales that produce no beta-lactamase

Only organisms producing metallo-beta-lactamases

Which enzyme group hydrolyses every beta-lactam except aztreonam?

Class B metallo-beta-lactamases such as NDM, IMP and VIM — The zinc-dependent class B enzymes dismantle the entire beta-lactam family with a single exception, and that exception is aztreonam. It is the whole reason a narrow, elderly agent still earns a place when NDM, IMP or VIM is present.

Class A serine carbapenemases such as KPC

Mutationally altered penicillin-binding proteins

Efflux pumps acting together with porin loss

Why is the statement "aztreonam resists all beta-lactamases" incorrect?

Class A serine carbapenemases, KPC among them, hydrolyse aztreonam as readily as penicillins, cephalosporins and carbapenems — The drug does survive many beta-lactamases and specifically escapes the class B enzymes, but that immunity is not general. Serine carbapenemases of class A take it apart just as they take apart the fused-ring agents, so the exception applies to one enzyme class only.

Metallo-beta-lactamases hydrolyse it more efficiently than they hydrolyse carbapenems

Porin loss is itself a form of enzymatic hydrolysis

Aztreonam contains no beta-lactam ring for any enzyme to attack

By which route or routes is aztreonam administered?

Parenterally, by intravenous or intramuscular injection, with an inhalational formulation also available — Systemic therapy with this molecule means injection, either into a vein or into muscle. A separate inhaled preparation delivers the same drug straight to the airway, so two routes exist and neither of them is swallowing a tablet.

Orally, with injection reserved for severe infection

Pharmacology · Cell wall synthesis inhibitors

Monobactams

A monocyclic beta-lactam class represented in practice by aztreonam, active against aerobic gram-negative bacilli.

Quick revision

Aztreonam is the monobactam: a monocyclic beta-lactam, parenteral, active mostly against aerobic gram-negative bacilli, and — uniquely among beta-lactams — not hydrolysed by metallo-beta-lactamases.

A synthetic monobactam with a monocyclic beta-lactam structure, originally isolated from Chromobacterium violaceum. (1)
Mechanism is the standard beta-lactam one: binds penicillin-binding proteins, inhibits cell-wall synthesis, decreases bacterial growth. (1)
Active mostly against gram-negative organisms, specifically aerobic gram-negative bacilli, and resistant to many beta-lactamases. (1)
In spectrum it more closely resembles the aminoglycosides than the penicillins. (1)
Class B metallo-beta-lactamases hydrolyse all beta-lactams except aztreonam — the single most examinable fact about this drug. (4)
Class A carbapenemases such as KPC do hydrolyse aztreonam, so the metallo-beta-lactamase exception is not a general one. (4)
Given parenterally; an inhalational formulation also exists. (1)

Overview

Aztreonam is a parenterally administered synthetic monobactam antibiotic. Where the penicillins and cephalosporins carry a beta-lactam ring fused to a second ring, the monobactam structure is monocyclic — a single beta-lactam ring standing alone. It was originally isolated from Chromobacterium violaceum. (1)

Its activity is concentrated on aerobic gram-negative bacilli, and it is resistant to many beta-lactamases. In practical terms its spectrum more closely resembles that of the aminoglycosides than that of the penicillins, which is a useful way to remember what it does and does not reach. (1)

The reason aztreonam still matters clinically, despite a narrow spectrum and an old registration, is a structural quirk: class B metallo-beta-lactamases hydrolyse every beta-lactam except this one. When an organism produces NDM, IMP or VIM, aztreonam is the beta-lactam still standing. (4)

Classification and drug examples

A single-agent class in practice. Rather than subdividing by spectrum, the useful split is by route, because the inhalational formulation exists for a different purpose from the systemic one.

Systemic monobactam

Given intravenously or intramuscularly for systemic gram-negative infection. (1)

Aztreonam (Azactam) · IV/IM — Used for moderate-to-severe systemic, skin, intra-abdominal, genitourinary and respiratory gram-negative infections. (1)

Inhalational monobactam

A separate inhaled formulation delivering the same molecule to the airway. (1)

Aztreonam for inhalation (Cayston) · Inhalation — An inhalational formulation of aztreonam. (1)

Mechanism of action

Aztreonam binds penicillin-binding proteins, inhibiting cell-wall synthesis and decreasing bacterial growth — the standard beta-lactam mechanism delivered by a monocyclic ring.

Molecular target: Penicillin-binding proteins (bacterial transpeptidases)
Killing effect: bactericidal
Kill kinetics: time-dependent

A single beta-lactam ring reaches the target
The monocyclic beta-lactam structure is what distinguishes monobactams from the fused-ring penicillins, cephalosporins and carbapenems, which all acylate the same transpeptidases from a two-ring scaffold. (1) (5)
It binds penicillin-binding proteins
Aztreonam binds penicillin-binding proteins, the transpeptidases that cross-link peptidoglycan. (1)
Cell-wall synthesis is inhibited
Inhibiting those enzymes prevents cell-wall synthesis and decreases bacterial growth. (1)
The structure also explains its survival
The same monocyclic structure is why class B metallo-beta-lactamases, which hydrolyse all other beta-lactams, cannot hydrolyse aztreonam. (4)

Spectrum of activity

Narrow and gram-negative. Learning what aztreonam does not cover matters as much as learning what it does.

Spectrum by subclass

Subclass	Gram-positive	Gram-negative	Anaerobes	Atypicals	Notable gaps
systemic	—	Aerobic gram-negative bacilli	—	—	Gram-positive organisms, Anaerobes (1)

Major clinical uses

Read each row as drug → organism → indication. Therapy is always directed by local susceptibility data and the treating clinician.

Drug	Organism	Indication	Role	Note
Aztreonam	Aerobic gram-negative bacilli	Moderate-to-severe systemic gram-negative infection	targeted	Chosen when gram-negative cover is needed and the organism is susceptible. (1)
Aztreonam	Aerobic gram-negative bacilli	Intra-abdominal infection	targeted	Gram-negative component only; anaerobic cover must come from elsewhere. (1)
Aztreonam	Aerobic gram-negative bacilli	Genitourinary infection	targeted	One of the licensed gram-negative indications. (1)
Aztreonam	Aerobic gram-negative bacilli	Skin and respiratory gram-negative infection	targeted	An inhalational formulation exists for airway delivery. (1)
Aztreonam	Metallo-beta-lactamase producers (NDM, IMP, VIM)	Infection where all other beta-lactams are hydrolysed	reserve	Class B enzymes hydrolyse every beta-lactam except aztreonam, which is what creates this niche. (4)

Pharmacokinetics

Drug	Route	Absorption	CSF penetration	Metabolism	Elimination	Half-life	Adjust in
Aztreonam	IV/IM	Parenteral administration required	See prescribing reference	See prescribing reference	See prescribing reference	See prescribing reference	See prescribing reference (1)
Aztreonam for inhalation	Inhalation	Delivered directly to the airway	Not applicable	See prescribing reference	See prescribing reference	See prescribing reference	See prescribing reference (1)

Because only one molecule represents this class, its handling in the body is best read directly from a current prescribing reference rather than generalised as a class property. (1)
This page gives no dose regimens by design. Doses depend on indication, organism, renal function, age and weight, and belong in a prescribing reference used by the treating clinician.

Adverse effects

Common

Injection site phlebitis: A common consequence of intravenous administration. (1)
Rash: Reported as a common side effect. (1)
Gastrointestinal symptoms: Reported as a common side effect. (1)

Serious adverse effects

Liver enzyme elevation: Asymptomatic elevations occur in roughly 10 to 38% of patients receiving high-dose intravenous therapy, though these are typically mild and self-limited. Interpret alongside the clinical picture; seek assessment if symptomatic liver disease develops. (1)
Hypersensitivity reactions, including anaphylaxis and angioedema: Cross-reactivity with other beta-lactams is rare, which is the basis of aztreonam's role in penicillin allergy. The exception is ceftazidime: the two share a structurally identical side chain, so a specifically ceftazidime-directed allergy warrants added caution. An allergy history is taken before administration; the drug is stopped and the reaction treated if one occurs. (2) (3)
Toxic epidermal necrolysis: Reported with aztreonam, described in bone marrow transplant recipients carrying multiple concurrent risk factors. The drug is stopped if a serious skin reaction develops. (2)

Contraindications, precautions and interactions

Precautions

Known hypersensitivity to aztreonam. Allergy history should always be established before any beta-lactam is given. (1)
Reliance on aztreonam for cover it does not provide. Because its activity is confined to aerobic gram-negative bacilli, gram-positive and anaerobic cover must come from another agent when both are needed. (1)

Resistance mechanisms

Class A serine carbapenemases

These enzymes hydrolyse penicillins, cephalosporins, carbapenems and aztreonam, so they defeat aztreonam along with everything else. (4)

Examples: KPC

Newer inhibitor combinations, directed by susceptibility testing.

Class B metallo-beta-lactamases — the exception

Zinc-dependent enzymes that hydrolyse all beta-lactams except aztreonam. This is why aztreonam retains a role against these organisms rather than losing one. (4)

Examples: NDM, IMP, VIM

Aztreonam itself, often paired with an agent that neutralises any co-produced serine enzyme.

Porin loss and efflux

Reduced permeability and active export limit how much drug reaches penicillin-binding proteins, independent of any enzyme. (4)

Susceptibility-directed therapy.

Aztreonam's value is highly situational: it is unremarkable as general gram-negative cover and genuinely important against metallo-beta-lactamase producers. Susceptibility testing is what tells those two situations apart.

High-yield exam pearls

Metallo-beta-lactamases spare aztreonam. (4) Class B carbapenemases hydrolyse every beta-lactam except aztreonam, which is what makes it a therapeutic option against NDM, IMP and VIM producers.
Aztreonam behaves more like an aminoglycoside than a penicillin in terms of what it covers. (1) Its activity is concentrated on aerobic gram-negative bacilli rather than the gram-positive and anaerobic range a penicillin reaches.
The exception does not extend to serine carbapenemases. (4) Class A enzymes including KPC hydrolyse penicillins, cephalosporins, carbapenems and aztreonam alike.
There is effectively one monobactam to learn. (1) Aztreonam is the agent that represents this class in practice, so the class and the drug are studied together.

Common exam traps

Trap: "Aztreonam resists all beta-lactamases." Actually: It is resistant to many beta-lactamases and specifically survives class B metallo-enzymes, but class A carbapenemases such as KPC hydrolyse it. (1) (4)
Trap: "Monobactams are broad-spectrum like carbapenems." Actually: Aztreonam is active mostly against gram-negative organisms, specifically aerobic gram-negative bacilli — a much narrower profile than a carbapenem. (1)
Trap: "Aztreonam can be given orally for gram-negative cover." Actually: It is administered parenterally, by intravenous or intramuscular injection, with an inhalational formulation available for a specific respiratory use. (1)

Self-test questions

Answers are hidden until you open them. These questions are written from this page's cited content and are for study only — they are not clinical guidance.

Which structural feature distinguishes a monobactam from the other beta-lactam classes?
- A beta-lactam ring fused to a thiazolidine ring
- Two beta-lactam rings joined in series
- No beta-lactam ring at all
- A single, monocyclic beta-lactam ring that is not fused to a second ring
Show answer
Answer: A single, monocyclic beta-lactam ring that is not fused to a second ring
Penicillins, cephalosporins and carbapenems all present their beta-lactam ring attached to a second ring; the monobactam scaffold carries just the one. Aztreonam, the agent that represents this class in practice, was originally obtained from Chromobacterium violaceum. (1)
How does aztreonam exert its antibacterial effect?
- It binds penicillin-binding proteins, so cell-wall synthesis is inhibited and bacterial growth falls
- It binds the 30S ribosomal subunit and causes misreading of the genetic code
- It binds the D-alanyl-D-alanine terminus of the peptidoglycan precursor
- It inhibits DNA gyrase and prevents supercoiling
Show answer
Answer: It binds penicillin-binding proteins, so cell-wall synthesis is inhibited and bacterial growth falls
Despite its unusual single-ring scaffold, aztreonam works in the conventional beta-lactam way. It attaches to the transpeptidases that cross-link peptidoglycan, and once wall construction is blocked the organism's growth declines. (1)
Aztreonam is selected to cover the gram-negative component of an intra-abdominal infection. Which organisms does it leave uncovered?
- Aerobic gram-negative bacilli
- Enterobacterales that produce no beta-lactamase
- Gram-positive organisms and anaerobes
- Only organisms producing metallo-beta-lactamases
Show answer
Answer: Gram-positive organisms and anaerobes
This drug's reach stops at aerobic gram-negative bacilli, which is a much narrower profile than a carbapenem offers. Anything gram-positive and anything anaerobic requires a second agent, so relying on aztreonam alone in a mixed abdominal picture leaves a gap. (1)
Which enzyme group hydrolyses every beta-lactam except aztreonam?
- Class A serine carbapenemases such as KPC
- Class B metallo-beta-lactamases such as NDM, IMP and VIM
- Mutationally altered penicillin-binding proteins
- Efflux pumps acting together with porin loss
Show answer
Answer: Class B metallo-beta-lactamases such as NDM, IMP and VIM
The zinc-dependent class B enzymes dismantle the entire beta-lactam family with a single exception, and that exception is aztreonam. It is the whole reason a narrow, elderly agent still earns a place when NDM, IMP or VIM is present. (4)
Why is the statement "aztreonam resists all beta-lactamases" incorrect?
- Metallo-beta-lactamases hydrolyse it more efficiently than they hydrolyse carbapenems
- Porin loss is itself a form of enzymatic hydrolysis
- Class A serine carbapenemases, KPC among them, hydrolyse aztreonam as readily as penicillins, cephalosporins and carbapenems
- Aztreonam contains no beta-lactam ring for any enzyme to attack
Show answer
Answer: Class A serine carbapenemases, KPC among them, hydrolyse aztreonam as readily as penicillins, cephalosporins and carbapenems
The drug does survive many beta-lactamases and specifically escapes the class B enzymes, but that immunity is not general. Serine carbapenemases of class A take it apart just as they take apart the fused-ring agents, so the exception applies to one enzyme class only. (1) (4)
By which route or routes is aztreonam administered?
- Orally only
- Parenterally, by intravenous or intramuscular injection, with an inhalational formulation also available
- Orally, with injection reserved for severe infection
- By inhalation only
Show answer
Answer: Parenterally, by intravenous or intramuscular injection, with an inhalational formulation also available
Systemic therapy with this molecule means injection, either into a vein or into muscle. A separate inhaled preparation delivers the same drug straight to the airway, so two routes exist and neither of them is swallowing a tablet. (1)

Frequently asked questions

What makes a monobactam different from a penicillin?

Structure. A monobactam has a monocyclic beta-lactam ring standing alone, whereas penicillins, cephalosporins and carbapenems carry a beta-lactam ring fused to a second ring. Aztreonam is the monobactam used in practice. (1)

Why is aztreonam useful against NDM-producing organisms?

Class B metallo-beta-lactamases, of which NDM is one, hydrolyse all beta-lactams except aztreonam. That single exception is what keeps it usable when every other beta-lactam has been inactivated. (4)

Does aztreonam cover gram-positive organisms or anaerobes?

No. Its activity is directed mostly at gram-negative organisms, specifically aerobic gram-negative bacilli. Cover for gram-positives or anaerobes has to come from another agent. (1)

How is aztreonam given?

Parenterally, by intravenous or intramuscular injection. An inhalational formulation is also available. (1)

References

Aztreonam (LiverTox) LiverTox, NIDDK / NCBI Bookshelf, 2020
AZACTAM (aztreonam for injection) — prescribing information DailyMed, U.S. National Library of Medicine
Penicillin Allergy (StatPearls) StatPearls Publishing / NCBI Bookshelf
Carbapenem-Resistant Enterobacterales (StatPearls) StatPearls Publishing / NCBI Bookshelf, 2024
Beta-Lactam Antibiotics (StatPearls) StatPearls Publishing / NCBI Bookshelf, 2023